Results 31 to 40 of about 16,360 (195)

Does Abatacept Induce Testicular Toxicity?

open access: yesThe Turkish Journal of Gastroenterology, 2020
Objectives: This study aims to demonstrate the effect of subcutaneous injections of abatacept on the histology of testes in mice. Materials and methods: The study included 20 male BALB/c mice (average weight, 25 g; aged 12-14 weeks).
Sultan AL-MOGAIREN
doaj   +3 more sources

Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy

open access: yesRespiratory Medicine Case Reports, 2017
This case report describes the re-administration of abatacept to successfully reduce the articularsymptoms of a patient with rheumatoid arthritisduring the intensive phase of anti-tuberculous therapy.
Hironori Kawamoto, M.D.   +9 more
doaj   +1 more source

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting

open access: yesArthritis Research & Therapy, 2018
Background Methotrexate (MTX) remains the anchor drug in rheumatoid arthritis (RA) treatment, but is poorly tolerated or contraindicated in some patients.
Rieke Alten   +8 more
doaj   +1 more source

Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major

open access: yesBlood Advances
: Iron overload in transfusion-dependent β-thalassemia (TDT) generates reactive oxygen species, predisposing to post–hematopoietic stem cell transplant (HSCT) endothelial activation. Abatacept prevents acute graft-versus-host disease (GVHD) by inhibiting
Pooja Khandelwal   +5 more
doaj   +1 more source

Une progression tumorale fulgurante sous abatacept

open access: yes, 2021
INTRODUCTION: La molécule de co-stimulation Cytotoxic T-lymphocyte antigen-4 (CTLA-4) inhibe l’activation lymphocytaire T. En thérapeutique, elle est ciblée de deux manières opposées : son blocage permet de restaurer l’immunité anti-tumorale en oncologie,
MERIGLIER, E.   +13 more
core   +1 more source

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

open access: yesArthritis Research & Therapy, 2018
Background To explore the effect of abatacept treatment on patient-reported outcomes (PROs) in psoriatic arthritis (PsA). Methods Patients with PsA were randomised (1:1) to subcutaneous abatacept 125 mg weekly/placebo for 24 weeks with early escape (EE ...
Vibeke Strand   +6 more
doaj   +1 more source

Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept [PDF]

open access: yes, 2014
A patient affected by rheumatoid arthritis developed a squamous-cell carcinoma probably due to abatacept, according to Naranjo algorithm. The case describes this adverse reaction for the first time and highlights the need for additional studies to ...
Maria Elena Sanna   +23 more
core   +1 more source

Abatacept in psoriatic arthritis: Case report and short review

open access: yes, 2013
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting about 6-10% of patients with cutaneous psoriasis. According to current knowledge, activated T-cells seem to play a pivotal role in the pathogenesis of both psoriasis and PsA. Abatacept
Naty, S.   +7 more
core   +2 more sources

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

open access: yesArthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee   +4 more
wiley   +1 more source

Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice

open access: yesBMC Pharmacology and Toxicology, 2019
Background Abatacept is increasingly used for rheumatoid arthritis (RA) and juvenile idiophathic arthritis (JIA) treatment. However little is known about the risk of hepatotoxicity.
Sultan M. Almogairen
doaj   +1 more source

Home - About - Disclaimer - Privacy